GRAIL, LLC (GRAL) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
Over the past 2 years, GRAIL, LLC has achieved a revenue compound annual growth rate (CAGR) of 50.4%, while earnings have grown at -38.7% CAGR.
Historical revenue and profitability trends for GRAIL, LLC
The chart above illustrates GRAIL, LLC's revenue trajectory over the past 2 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of GRAIL, LLC's business.
How efficiently GRAIL, LLC converts revenue into profit
Profit margins reveal how much of each dollar of revenue GRAIL, LLC retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project GRAIL, LLC to continue focusing on sustainable operations. The consensus analyst rating is 3.5 based on 4 analysts.
Based on our comprehensive analysis, GRAIL, LLC (GRAL) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of GRAIL, LLC's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how GRAIL, LLC stacks up against similar companies
Explore growth analysis for top stocks
Related: GRAL Valuation, GRAL Dividend, GRAL Financial Health
Compare: GRAL vs AAPL, GRAL vs MSFT, GRAL vs GOOGL